Latest News
Cedar Health Research opens new embedded research site within Texas Native Health
19 February 2026 - Cedar Health Research, a Texas-based clinical trial network focused on underserved patients, and Texas Native Health, a Dallas nonprofit serving American Indian and Alaska Native communities, announced on Wednesday that they have o...
Hansa's imlifidase Biologics License Application accepted by FDA
19 February 2026 - Swedish biopharmaceutical company Hansa Biopharma AB (STO:HNSA) announced on Wednesday that the US Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) for imlifidase.The FDA's filing review ...
Novartis reports positive Phase III results for remibrutinib in chronic inducible urticaria
...
Merck and Mayo Clinic launch AI-driven drug discovery collaboration
18 February 2026 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, on Wednesday announced a research and development agreement with Mayo Clinic to apply artificial intelligence (AI), machine learning (...
Palisade Bio makes Clinical Advisory Board appointment
18 February 2026 - Clinical-stage biopharmaceutical company Palisade Bio Inc (Nasdaq:PALI) announced on Tuesday the appointment of Bram Verstockt, MD, PhD, to its Clinical Advisory Board.The company said that Dr. Verstockt is an internationally recog...